Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Carbamic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbamic Acid SCHEMBL3845940 | 1.00 | — | — | |
| Carbamic Acid SCHEMBL11241925 | 1.00 | — | — | |
| Carbamic Acid SCHEMBL18765304 | 1.00 | — | — | |
| Carbamic Acid SCHEMBL201906 | 1.00 | — | — | |
| Carbamic Acid SCHEMBL10506103 | 0.94 | — | — | |
| Carbamic Acid SCHEMBL28194568 | 0.94 | — | — | |
| Carbamic Acid SCHEMBL10802450 | 0.94 | — | — | |
| Carbamic Acid SCHEMBL27930001 | 0.94 | — | — | |
| Carbamic Acid SCHEMBL15667943 | 0.94 | — | — | |
| Carbamic Acid SCHEMBL27335487 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110300759-A | The new compound of anti-mycobacteria | 悉尼大学 | 2019-10-01 | — | — | CN | claimed |
| CN-109758468-A | Medical usage of the N- benzene substitution -2- hypoxanthine sulfenyl acetamide derivative in Killing Mycobacterium Tuberculosis infection | 中国药科大学 | 2019-05-17 | — | — | CN | claimed |
| CN-108314065-A | Divide the full membrane separating method that salt produces lithium liquor by salt lake bittern multistage nanofiltration | 陕西省膜分离技术研究院有限公司 | 2018-07-24 | — | — | CN | claimed |
| CN-106860468-A | A kind of formula for treating phthisical pharmaceutical composition and preparation method thereof | 新乡医学院第附属医院 | 2017-06-20 | — | — | CN | claimed |
| EP-3154983-A1 | SOLID FORMS OF AN ANTIVIRAL COMPOUND | Gilead Pharmasset LLC (US) | 2017-04-19 | — | — | EP | claimed |
| CN-104772160-B | A kind of carbonitride photocatalytic activity nano fibrous membrane and preparation method thereof | 北京师范大学 | 2017-03-15 | — | — | CN | claimed |
| WO-2015191431-A1 | SOLID FORMS OF AN ANTIVIRAL COMPOUND | GILEAD PHARMASSET LLC (US) | 2015-12-17 | — | — | WO | claimed |
| CN-104772160-A | Carbon nitride photocatalytic activity nano fiber membrane and preparation method thereof | UNIV BEIJING NORMAL | 2015-07-15 | — | — | CN | claimed |
| US-8829028-B2 | 5-HT4 receptor antagonists for the treatment of heart failure | SERODUS AS (NO) | 2014-09-09 | — | — | US | claimed |
| CN-102633737-A | Synthesis of triazine amide organic acid | JIANDONG XIU | 2012-08-15 | — | — | CN | claimed |
| CN-102559844-A | Preparation method of detecting system for minimal inhibitory concentration of mycobacteria | UNIV SHANGHAI JIAOTONG | 2012-07-11 | — | — | CN | claimed |
| CN-102491952-A | Synthesis process of triazine amide | SICHUAN LESHAN FUHUA TONGDA AGRO CHEMICAL TECHNOLOGY CO LTD | 2012-06-13 | — | — | CN | claimed |
| CN-102380107-A | Method for detecting whether patient is allergic to medicine | UNIV PLA 3RD MILITARY MEDICAL | 2012-03-21 | — | — | CN | claimed |
| CN-102188655-A | Molecular Chinese patent medicine for inhibiting defects of Lifei tablets and syndromes of pulmonary tuberculosis | MIN YANG | 2011-09-21 | — | — | CN | claimed |
| US-20090169545-A1 | 5-HT4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF HEART FAILURE | SERODUS AS (NO) | 2009-07-02 | — | — | US | claimed |
| US-20060094715-A1 | 5-Ht4 receptor antagonists for the treatment of heart failure | SERODUS AS (NO) | 2006-05-04 | — | — | US | claimed |
| CN-1644536-A | Surface active agent waste water rapid treating, circulating and recovering method | UNIV SHANGHAI COMMUNICATION (CN) | 2005-07-27 | — | — | CN | claimed |
| CN-1297352-A | Use of organophosphorous compounds for the therapeutic and prophylactic treatment of infections | HASSAN JOMAA (DE) | 2001-05-30 | — | — | CN | claimed |
| CN-122074043-A | Combination therapy with KRAS modulators | 光达治疗公司 | 2026-05-22 | — | — | CN | disclosed |
| US-3947484-A | Continuous prephosgenation process for the production of organic isocyanates | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-30 | — | — | US | disclosed |